Michael B. Jebsen's most recent trade in Tenax Therapeutics Inc was a trade of 70,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Jan. 5, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tenax Therapeutics Inc | Michael B. Jebsen | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 70,000 | 70,000 | - | - | Stock option (right to buy) |